EX-10.79 2 v367396_ex10-79.htm EX-10.79 Note: Portions of this document have been marked “[c.i.]” to indicate that confidential treatment has been requested for certain redacted confidential information. The confidential portions have been submitted...Exclusive License and Technology Transfer Agreement • May 5th, 2020 • New York
This EXCLUSIVE LICENSE AND TECHNOLOGY TRANSFER AGREEMENT (this “Agreement”), dated as of December 9, 2013 (the “Effective Date”), is made by and between Advaxis Inc. (“Advaxis”), a Delaware corporation, having its principal place of business at 305 College Road East, Princeton, New Jersey, and Global BioPharma, Inc. (“Licensee”), a corporation organized under the laws of Republic of China, having a place of business at 6F, No.10, LinSen S. Road, Taipei City, Taiwan, R.O.C. Advaxis and Licensee are individually referred to as a “Party” and collectively as the “Parties.”
